Emergent Biosolutions Inc

NYSE:EBS   3:59:50 PM EDT
28.57
-0.82 (-2.79%)
Products

Emergent BioSolutions Says FDA Accepts BLA For Anthrax Vaccine Candidate

Published: 06/24/2022 10:47 GMT
Emergent Biosolutions Inc (EBS) - Emergent Biosolutions Announces FDA Acceptance of Biologics License Application for Av7909 Anthrax Vaccine Candidate.
Emergent Biosolutions Inc- Prescription Drug User Fee Act Goal Date for a Decision by FDA is in April 2023.